KiraGen Bio
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
127 Western Ave, Allston, Massachusetts,...Website
www.kiragenbio.comRevenue
$5 MillionIndustry
About KiraGen Bio
KiraGen Bio specializes in developing multiplex-edited CAR-T therapies aimed at treating solid tumors, with a primary focus on recurrent glioblastoma. Their lead program, KGEN-001, utilizes engineered healthy-donor CAR-T cells designed to resist tumor suppressive signals. The company employs a unique approach that combines machine learning and experimental data to prioritize protective gene edits for enhanced durability in cancer treatment. KiraGen Bio is backed by investors and disease foundations, reflecting its commitment to advancing innovative cancer therapies.Explore more
SIC Code 28,283NAICS Code 32,325Show more
KiraGen Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
KiraGen Bio Tech Stack
A closer look at the technologies used by KiraGen Bio
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding KiraGen Bio
Sign Up For FreeTo access detailed company insights
KiraGen Bio specializes in developing multiplex-edited CAR-T therapies aimed at treating solid tumors, with a primary focus on recurrent glioblastoma. Their lead program, KGEN-001, utilizes engineered healthy-donor CAR-T cells designed to resist tumor suppressive signals. The company employs a unique approach that combines machine learning and expe... Read More
